Moody's has downgraded Volkswagen's outlook to 'negative' due to weak operating performance and declining sales, highlighting challenges in the automotive industry.
Moody's Investors Service has revised its outlook on Volkswagen AG, Europe's leading car manufacturer, from 'stable' to 'negative'. This decision comes as a result of Volkswagen's deteriorating operating performance and the significant challenges it faces in reversing this trend. The rating agency cited low global volume growth, particularly in China and Western Europe, increasing price pressures, potential EU CO2 emission fines, and additional restructuring costs as key factors influencing this downgrade.
Volkswagen's struggles are further underscored by a reported 7% decline in third-quarter global deliveries. The company, which is undergoing a major restructuring, is grappling with weak demand from China, high production costs in Germany, and the competitive pressures of vehicle electrification. The potential for a trade war between the European Union and China, due to EU tariffs on Chinese electric vehicles, adds another layer of complexity to the situation.
In China, Volkswagen's most crucial market, deliveries fell by 15%, contributing significantly to the global decline. The company is also facing stiff competition from local Chinese manufacturers offering more affordable electric vehicles. Despite efforts to cut costs and boost electric vehicle sales, Volkswagen's global electric vehicle deliveries fell by 9.8% in the third quarter.
The challenges are not unique to Volkswagen, as other European carmakers like BMW and Mercedes-Benz are also experiencing sluggish demand and increased competition in China. However, Volkswagen's situation is particularly acute, prompting the company to lower its annual sales outlook for the second time in three months, now expecting to deliver around 9 million vehicles this year, down from previous estimates.
Volkswagen is taking steps to address these issues, including price reductions on its electric models like the ID.3, in an effort to boost sales and meet EU CO2 targets. However, the company acknowledges that more affordable electric models, such as the planned ID.2 and ID.1, will not be available until 2026, which may impact its ability to meet regulatory requirements in the near term.
Party City, a leading retailer in the party supplies industry, has filed for bankruptcy and announced the closure of all its stores, marking the end of nearly 40 years in business.
Honda and Nissan are in talks for a potential merger to address financial struggles and enhance competitiveness in the electric vehicle market.
Google has proposed to loosen its search engine agreements with companies like Apple to address antitrust concerns, while the US government pushes for more drastic measures.
The US FDA has approved Novo Nordisk's Alhemo, a groundbreaking treatment for hemophilia A and B with inhibitors, marking a significant advancement in hemophilia care.
The US FDA has declined to approve Lexicon Pharmaceuticals' Zynquista as an add-on treatment for type 1 diabetes and chronic kidney disease, prompting the company to shift focus to other drug candidates.
Sarepta Therapeutics Inc. has secured a $115.2 million verdict against Nippon Shinyaku Co. Ltd. for patent infringement related to its Duchenne muscular dystrophy drug, Vyondys 53.
A US jury remains deadlocked in the high-stakes trial between Arm Holdings and Qualcomm over a licensing dispute involving Nuvia's chip designs, with deliberations ongoing.
Netflix has acquired the exclusive U.S. broadcasting rights for the FIFA Women's World Cup in 2027 and 2031, marking a significant move into live sports for the streaming giant.
Carnival Corporation & plc has reported record earnings for 2024, surpassing guidance and setting a positive outlook for 2025 with expected earnings growth and strong booking volumes.
United States Steel Corporation's stock has taken a hit following a weaker-than-expected fourth-quarter outlook, with projected losses and challenges in the steel market.